Heterocyclic hydrazone compounds and their uses to treat cancer and inflammation

Details for Australian Patent Application No. 2010283806 (hide)

Owner Novartis AG

Inventors Fu, Xingnian; He, Feng; Li, Yue; Liu, Lei; Mi, Yuan; Xu, Yao-Chang; Xun, Guoliang; Yu, Zhengtian; Zhang, Ji Yue (Jeff); Dai, Miao

Agent Davies Collison Cave

Pub. Number AU-A-2010283806

PCT Pub. Number WO2011/018454

Priority 61/233,328 12.08.09 US; PCT/ CN2010/074078 18.06.10 CN; PCT/ CN2010/071981 21.04.10 CN

Filing date 10 August 2010

Wipo publication date 17 February 2011

International Classifications

C07D 487/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

A61K 31/4985 (2006.01) - Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

1 March 2012 PCT application entered the National Phase

  PCT publication WO2011/018454 Priority application(s): WO2011/018454

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010283807-Vector comprising mannose promoter and mannose promoter

2010283769-Inhibitors of JNK